소화기내과
안상봉 교수
- [전문분야]
- 간질환(지방간, 간염, 간경변), 췌담도질환, 위장관질환
- [전문진료]
찾아주시는 소중한 환자분 모두 내 가족과 같이 생각하며 진료하겠습니다.
저는 환자의 마음을 공감하며 보호자와 함께 고민하는 것을 진료의 첫걸음으로 생각합니다. 또한 끊임없는 연구를 통해 최신 과학에 기반을 둔 과학적이고 합리적인 치료 및 진료 서비스를 제공하는데 노력하고 있습니다.
내원하시는 모든 분들이 신뢰하고 의지할 수 있도록, 사람을 중심에 두는 진료를 하겠습니다.
논문
- Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease. J Hepatol 2025 Dec
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort. Liver Int 2026 Mar
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs. J Viral Hepat 2025 Oct
Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study. Eur J Gastroenterol Hepatol 2025 Oct
Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study. EClinicalMedicine 2025 Aug
Hepatic Steatosis in Cardiovascular-Kidney-Metabolic Syndrome: Fatty Liver Index as a Predictor of Cardiovascular Outcomes. Eur J Prev Cardiol 2025 Jun
Impact of components of metabolic syndrome on long-term outcomes of CHB with nucleos(t)ide analogue treatment. Clin Mol Hepatol 2025 Mar
Clinical Course and Prognosis of Long-Term Survivors of Hepatocellular Carcinoma. Aliment Pharmacol Ther 2025 Apr
Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort. J Hepatol 2024 Nov
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study. J Gastroenterol Hepatol 2024 Jun
Harnessing Metabolic Indices as a Predictive Tool for Cardiovascular Disease in a Korean Population without Known Major Cardiovascular Event. Diabetes Metab J 2024 May
Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis. World J Pediatr 2024 Jun
Barriers to care linkage and educational impact on unnecessary MASLD referrals. Front Med 2024 Jul
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study. J Clin Transl Hepatol 2024 Jul
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs. Kaohsiung J Med Sci 2024 Feb
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study. Aliment Pharmacol Ther 2024 Jan
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study. Clin Gastroenterol Hepatol 2024 Mar
Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area. Cancers 2023 Dec
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study. Am J Gastroenterol 2023 Nov
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B. Sci Rep 2023 Jun
A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population. Sci Rep 2023 Sep
Different Associations of Coffee Consumption with the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Liver Fibrosis. Nutrients 2023 Dec
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments. Clin Mol Hepatol. 2023 Feb
Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis. Dig Liver Dis. 2023 Jan
Personalized Antiviral Drug Selection in Chronic Hepatitis B Patients Using a Machine Learning Model: A Multinational Study. Am J Gastroenterol. 2023 Mar 7
Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis. J Pers Med. 2022 Nov 26
Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis. J Pers Med. 2022 Sep
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort. Hepatol Int. 2022 Dec
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly. Clin Mol Hepatol. 2023 Jan;29(1):120-134.
Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients. 2022 Jul 24;14(15):3039
The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Clin Mol Hepatol. 2022 Oct;28(4):814-826
Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Korean J Intern Med. 2022 Jul;37(4):757-767.
Efficacy and safety of direct-acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta-analysis. J Viral Hepat. 2022 Jul;29(7):496-517.
Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Gut Liver. 2022 Nov 15;16(6):952-963
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study. Hepatol Int. 2022 Feb;16(1):48-58.
BTT-105 ameliorates hepatic fibrosis in non-alcoholic fatty liver animal model. FASEB J. 2021 Nov;35(11):e21979
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients. Liver Int. 2022 Jan;42(1):59-68
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B. J Hepatol. 2022 Feb;76(2):311-318.
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1343-1353
Ahn SB, Jun DW, Kang BK, Kim M, Chang M, Nam E. Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting. Medicine. 2018
Ahn SB, Jun DW, Jang K, Lee BH, Shin KJ. Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease. Korean J Internal Med. 2018
Ahn SB, Wu WH, Lee JH, Jun DW, Kim J, Kim R, Lee TB, Jun JH. Fermented soymilk alleviates lipid accumulation by inhibition of SREBP-1 and activation of NRF-2 in the hepatocellular steatosis model. J Microbiol Biotechnol. 2017
Jun DW, Ahn SB (co-1st author), Kim TY, Sohn JH et al. Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study). Chin Med J. 2018
Park J, Lee EY, Ahn SB et al. NASH/liver fibrosis prevalence and incidence of non-liver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidites: Lessons from South Korea. Dig Dis 2021
Liu M, Tseng TC, Ahn SB et al. Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients. Hepatol Int 2021
Tanaka Y, Ahn SB et al. HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort. Hepatol Int 2020 Dec
Ogawa E, Toyoda H, Iio E, Jun DW, Ahn SB, et al. HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. Clin Infect Dis. 2019 Nov
Oh H, Yoon EL, Jun DW, Ahn SB,et al. No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Treated With Entecavir vs Tenofovir. Clin Gastroenterol Hepatol. 2020 Nov
Jeong JY, Jun DW, Park SJ, Sohn JH, Ahn SB, et al. Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study. Korean J Intern Med. 2020 Sep
Yoon EL, Jun DW, Jeong JY, Kim TY, Song DS, Ahn SB, et al. Validation of the Korean Stroop Test in Diagnosis of Minimal Hepatic Encephalopathy. Sci Rep. 2019 May
Saeed WK, Jun DW, Jang K, Ahn SB, et al. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease. World J Gastroenterol 2018
